Sign up today to learn more about GenapSys stock

EquityZen is a marketplace for shares of proven pre IPO tech companies

GenapSys Stock

DNA Sequencing Technology

Founded

2010

Notable Investors

Oxford Finance Corporation

Headquarters

Redwood City CA, US

Total Funding

$201M

About GenapSys Stock

GenapSys is a medical technology company that develops low-cost DNA sequencers.  With its sequencing technology, the company aims to help support the control and limit the spread of current and future outbreaks. The device can run off of a standard power source and is small enough to fit in the back of a truck or be deployed at hospitals, airports, and public transportation hubs for quick results on virus samples.

GenapSys was founded in 2010 and is headquartered in Redwood City, California.

Investors

Foresite Capital

EverlyWell, Aetion, GenapSys, DNAnexus

IPV Capital

GenapSys, Amprius

Oxford Finance Corporation

GenapSys

Funding History

March 2013$8.5M
November 2013$36.5M
December 2017$86.2M
February 2021$70.0M

Management

Chief Executive Officer

Jason Myers

Chief Financial Officer

Britton Russell

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from GenapSys or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 190K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo